Discovery Chemistry
Integrated discovery chemistry providing comprehensive services to speed up the early-stage drug discovery process with unparalleled capabilities.

WuXi Biologics
Offering End-to-End Solutions
Small Molecule Discovery
Dedicated to Efficient Discovery of Hits,
Leads and Preclinical Candidates for Small Molecules
Integrated discovery chemistry providing comprehensive services to speed up the early-stage drug discovery process with unparalleled capabilities.
Developed and increasing special chemistry platforms to fulfill the special chemistry needs and enhance the discovery process with decades of accumulated experience and expertise.
Rich experience on route design, route scouting and condition optimization with the support of experienced chemists, comprehensive platforms and flexible service modes to ensure the rapid development of a robust and scalable route to accelerate the drug discovery process.
Dedicated analytical team for analysis, separation, purification and quality control, aiming to provide solid analytical services with state-of-art instruments and methods. We have successful results with different types of molecules such as small molecules, liposomes, polypeptides, protein degraders, carbohydrates and polymers with high recovery rate ranging from mg to kg.
Cutting-edge technology platform to expand the synthesis toolbox, to deliver quality compounds in a more efficient, safer and reliable way. Platforms include use of automation, flow chemistry, electrochemistry and photochemistry tools.
Backed by WuXi LabNetwork, a global eCommerce platform to connect customers and suppliers, providing research chemicals and reagents service with massive products.
One-stop management from project timelines to compound flow, aiming to provide our clients the best experience.
Research Chemistry Services (RCS) is a global leading chemistry platform delivering synthetic and
medicinal chemistry solutions to global pharma, biotech companies, research institues and non-profit foundations.
As an integrated small molecule drug discovery platform,
WuXi Chemistry RCS provides both FTE (Full-time Equivalent) and FFS (Fee-for-Service) to
expedite the drug discovery process with productivity, speed, flexibility, quality and reliability.
The field of KRAS research is at an undeniably exciting crossroads. Medicines on the market have proved the “undruggable” could be drugged. Combination trials are on the move, searching out regimens that effectively fight against acquired resistance. A wave of new options is on the horizon that will expand treatments over the next few years.
SHANGHAI, January 12, 2025 – WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life sciences industries, announced that it has joined the Pharmaceutical Supply Chain Initiative (PSCI) as a Supplier Partner, underscoring the company’s enduring commitment to responsible business practices and supply chain resilience.
Library synthesis is the process of synthesizing a series of compounds and evaluating them for hits that have desirable therapeutic properties toward a given target. This approach allows project teams to undertake efficient and systematic screening of biological pathways or target classes, improving the success rate of drug discovery programs. Pharma companies are increasingly developing and applying innovative capabilities to make better molecules faster. Many enabling chemistries and technologies have been developed to improve the access to target molecules with expanded chemical diversity.
Get in touch with an expert.